Company / Free Cash Flow
INSMED Inc Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$967.6M
FY2025
5-year range
-$967.6M / -$370.6M
FY2021-FY2025
Trend
-37.1%
vs FY2024
Sector context
#193 of 194
Health Care
What the data says
Among 194 Health Care companies, INSMED Inc is in the bottom 1% for free cash flow. Free Cash Flow has declined for 5 consecutive years, from -$226M in FY2020 to -$968M in FY2025.
Based on SEC 10-K filings.
-$968M in FY2025.
Declined from -$550M to -$968M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 194This company -$967.6M Sector average $470.6M
▼
-305.6% below sector average
Key checks
Key Insights
- INSMED Inc's free cash flow has declined for 5 consecutive years.
- In FY2025, free cash flow decreased 37.1% year-over-year.
- Ranks #193 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$967.6M | -37.1% |
| FY2024 | -$705.8M | -28.4% |
| FY2023 | -$549.5M | -33.9% |
| FY2022 | -$410.3M | -10.7% |
| FY2021 | -$370.6M | -64.3% |
| FY2020 | -$225.6M | +23.0% |
| FY2019 | -$292.9M | -8.1% |
| FY2018 | -$271.1M | -66.7% |
| FY2017 | -$162.6M | -7.8% |
| FY2016 | -$150.9M | -44.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026